µ¿¹°¿ë º¸Á¶»ý½Ä±â¼ú ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® ¸®Æ÷Æ® : ¼öÅ ¹æ¹ýº°, µ¿¹° À¯Çüº°, À¯Åë ä³Îº°, Á¦Ç°º°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2030³â)
Veterinary Assistive Reproduction Technology Market Size, Share & Trends Analysis Report By Conception Method, By Animal Type, By Distribution Channel, By Product, By Region, And Segment Forecasts, 2024 - 2030
»óǰÄÚµå
:
1405867
¸®¼Ä¡»ç
:
Grand View Research, Inc.
¹ßÇàÀÏ
:
2023³â 12¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 146 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
µ¿¹°¿ë º¸Á¶»ý½Ä±â¼ú ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :
Grand View Research, Inc.ÀÇ ÃֽЏ®Æ÷Æ®¿¡ µû¸£¸é ¼¼°èÀÇ µ¿¹°¿ë º¸Á¶»ý½Ä±â¼ú ½ÃÀå ±Ô¸ð´Â 2024-2030³â 7.42%ÀÇ CAGR·Î ¼ºÀåÇϸç, 2030³â±îÁö 42¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.
½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î´Â µ¿¹° »ý½Ä º¸Á¶ ÀÇÇÐÀÇ ¹ßÀü, ¿¬±¸°³¹ß Ȱµ¿ Áõ°¡, µ¿¹°¼º ´Ü¹éÁú¿¡ ´ëÇÑ ¼ö¿ä, µ¿¹°ÀÇ ¹ø½Ä °á°ú °³¼±¿¡ ´ëÇÑ °ü½É Áõ°¡ µîÀÌ ÀÖ½À´Ï´Ù. Àΰø¼öÁ¤ÀÇ ºñ¿ë È¿À²¼ºÀº ¹ø½Ä °á°ú °³¼±ÀÌ ¼öÀͼº¿¡ Á÷Á¢ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡´Â Ãà»ê¾÷¿¡¼ äÅ÷ü¿¡ ´õ ¸¹Àº ¿µÇâÀ» ¹ÌÄ¡°í ÀÖÀ¸¸ç, 2019³â 6¿ù National Library of Medicine Journal¿¡ °ÔÀçµÈ ¿¬±¸¿¡ µû¸£¸é ¾Ï¼ö Á¤¾×(X-¼ÒÆ®) ¹× ³Æ÷ ¼ºÀå ÀÚ±Ø(FGS) ³ÀÚ¸¦ ÀÌ¿ëÇÑ ¹è¾Æ »ý»êÀº ´Ù¸¥ ¹è¾Æ µ¿Á¾±³¹è ¹æ¹ýº¸´Ù ´õ È¿À²ÀûÀ¸·Î ¾Ï¼Ò¸¦ ¹ø½Ä½ÃŰ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.
COVID-19 ÆÒµ¥¹Í°ú ¾ÆÇÁ¸®Ä«µÅÁö¿º´Àº ½ÃÀå ¼ºÀå µÐÈ, °ø±Þ¸Á ¹®Á¦, °æ¿µ»óÀÇ Àå¾Ö¹° µî ´«¿¡ ¶ç´Â ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº 2022-23³â µ¿¾È ƯÁ¤ ½ÃÀå(Áß±¹ µî)¿¡ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ±×·¯³ª ±Ùº»ÀûÀÎ ÃËÁø¿äÀο¡ º¯È°¡ ¾ø±â ¶§¹®¿¡ ½ÃÀåÀº ¿¹Ãø ±â°£ Áß »ó´çÇÑ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½ÃÀå ¿ªÇÐÀº Áö¿ª¸¶´Ù ´Ù¸£¸ç, µ¿¹° Àα¸, °æÁ¦ »óȲ, ¹Ý·Áµ¿¹° ¹× °¡Ãà¿¡ ´ëÇÑ ¹®ÈÀû ŵµ, ±ÔÁ¦ ȯ°æ µîÀÇ ¿äÀο¡ µû¶ó ±¹°¡¸¶´Ù µµÀÔ ¼öÁØÀÌ ´Ù¸¨´Ï´Ù. ¶ÇÇÑ »ý½Ä ±â¼úÀÇ ¹ßÀüÀ¸·Î ¼ö¼ú ¼º°ø·üÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ È¿À²¼º Çâ»óÀº °¡±î¿î ¹Ì·¡¿¡ µ¿¹° º¸Á¶»ý½Ä¼úÀÇ Ã¤ÅÃÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Ãà»ê ºÎ¹®Àº 2023³â °¡Àå ³ôÀº ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¹Ãø ±â°£ Áß¿¡µµ ±× ¿ìÀ§¸¦ À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â Ãà»ê ºÎ¹®ÀÌ ¿À·§µ¿¾È ¹ø½Ä È¿À²À» ³ôÀÌ°í °¡ÃàÀÇ À¯ÀüÀû ÇüÁúÀ» °³¼±ÇÏ°í ³ó¾÷ »ý»ê¼ºÀ» ³ôÀ̱â À§ÇØ »ý½Ä ±â¼úÀ» äÅÃÇØ ¿Ô±â ¶§¹®ÀÔ´Ï´Ù. ¶ÇÇÑ ´Ù¾çÇÑ µ¿¹° º¸Á¶»ý½Ä¼úÀÇ ÀáÀç·ÂÀº °¡±î¿î ¹Ì·¡¿¡ ÀÎÁöµµ, ¼ö¿ä ¹× äÅÃÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î ºê¶óÁú ³ó¾÷¿¬±¸°ø»ç(Embrapa)´Â Àΰø¼öÁ¤À» ÅëÇÑ ¹ø½Ä±â¼úÀÇ ÀáÀç·ÂÀ» ÃßÁ¤ÇÏ¿© ¿¬°£ 1¸¶¸®ÀÇ ¼Û¾ÆÁö¸¦ ¾òÀ» ¼ö ÀÖµµ·Ï Àå·ÁÇϰí ÀÖ½À´Ï´Ù. °íÀüÀû ¹è¾Æ À̽Ä(ET)Àº ¸Å¿ù 1¸¶¸®, ü¿Ü¼öÁ¤Àº ÁÖ´ç 1¸¶¸®ÀÇ ¼Û¾ÆÁö°¡ ž °ÍÀ¸·Î ÃßÁ¤Çϰí ÀÖ½À´Ï´Ù.
µ¿¹°¿ë º¸Á¶»ý½Ä¼ú ½ÃÀå º¸°í¼ ÇÏÀ̶óÀÌÆ® :
Á¦Ç°º°·Î´Â 2023³â¿¡´Â ÀÏ¹Ý Á¤¾× ºÎ¹®ÀÌ ¾÷°è¸¦ Áö¹èÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2024-2030³â À¯¼º Á¤¾× ºÎ¹®ÀÌ °¡Àå ºü¸¥ CAGR 8.0% ÀÌ»óÀ¸·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
µ¿¹° º¸Á¶»ý½Ä¼ú¿¡ ´ëÇÑ ÀÎ½Ä °³¼±°ú º¸±ÞÀº ½ÃÀå ¼ºÀå¿¡ ±â¿©ÇÏ´Â Áß¿äÇÑ ¿äÀÎÀÔ´Ï´Ù.
À¯Åë ä³Îº°·Î´Â ¹Î°£ ºÎ¹®ÀÌ 2023³â °¡Àå ³ôÀº ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2024-2030³â °¡Àå ºü¸¥ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
AI ¼öÁ¤¹ý ºÎ¹®Àº 2023³â¿¡ ¾÷°è¸¦ ÁÖµµÇß½À´Ï´Ù. ±×·¯³ª IVF ºÎ¹®Àº 2024-2030³â °¡Àå ºü¸¥ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.
¼Ò µ¿¹° À¯Çü ºÎ¹®Àº 2023³â °¡Àå ³ôÀº ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ±âŸ µ¿¹° ºÎ¹®Àº 2024-2030³â °¡Àå ºü¸¥ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÇöÀç ÁøÇà ÁßÀÎ R&D ³ë·ÂÀº ´Ù¾çÇÑ µ¿¹° À¯ÇüÀÇ Æ¯Á¤ °úÁ¦¸¦ ÇØ°áÇϱâ À§ÇØ ±âÁ¸ ±â¼úÀ» °³¼±Çϰí, ±âÁ¸ ±â¼úÀ» ºñ±³Çϰí, ¹ø½Ä ¼ºÀûÀ» Çâ»ó½Ãų ¼ö ÀÖ´Â »õ·Î¿î ¹æ¹ýÀ» ¸ð»öÇÏ´Â µ¥ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù. À̰ÍÀÌ ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀ» Áö¿øÇÏ´Â °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.
2023³â ºÏ¹Ì°¡ °¡Àå ³ôÀº ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº 2024-2030³â °¡Àå ºü¸¥ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå µ¿¹°¿ë º¸Á¶»ý½Ä±â¼ú ½ÃÀå ¾÷°è Àü¸Á
½ÃÀå °èÅë Àü¸Á
µ¿¹°¿ë º¸Á¶»ý½Ä±â¼ú ½ÃÀå ¿ªÇÐ
µ¿¹°¿ë º¸Á¶»ý½Ä±â¼ú ½ÃÀå : Porter's Five Forces ºÐ¼®
µ¿¹°¿ë º¸Á¶»ý½Ä±â¼ú ½ÃÀå : PESTEL ºÐ¼®
ÁÖ¿ä ±¹°¡ ¹× ÁÖ¿ä Á¾·ùº° ÃßÁ¤ µ¿¹° °³Ã¼¼ö, 2022³â
ÁÖ¿ä ±¹°¡º° ÃßÁ¤ Á¤¾× ÆÇ¸Å ¼ö·®(2022³â)
COVID-19ÀÇ ¿µÇ⠺м®
ÁÖ¿ä Áö¿ªº° °¡°Ý ºÐ¼®
±â¼ú µ¿Çâ
¼öÁ¤À²/¼öÅÂÀ² Á¤¼º ºÐ¼®
Á¦4Àå Á¦Ç° ÃßÁ¤¡¤µ¿Ç⠺м®, 2018-2030³â
Á¦Ç°º° µ¿¹°¿ë º¸Á¶»ý½Ä±â¼ú ½ÃÀå : ÁÖ¿ä Æ÷ÀÎÆ®
Á¦Ç° º¯µ¿ ºÐ¼®°ú ½ÃÀå Á¡À¯À², 2023³â°ú 2030³â
Á¦Ç°º°
ÀÏ¹Ý Á¤¾×
ÀÏ¹Ý Á¤¾× ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â
À¯¼º Á¤¾×
À¯¼º Á¤¾× ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â
Á¦5Àå ¼öÅ ¹æ¹ý ÃßÁ¤¡¤µ¿Ç⠺м®, 2018-2030³â
¼öÅ ¹æ¹ýÀÇ º¯µ¿ ºÐ¼®, 2018-2030³â
¼öÅ ¹æ¹ýÀÇ º¯µ¿ ºÐ¼®°ú ½ÃÀå Á¡À¯À², 2023³â°ú 2030³â
Âø»ó¹ýº°
Àΰø¼öÁ¤
Àΰø¼öÁ¤ ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â
¹èÀ̽Ä(Moet : º¹¼ö ¹è¶õ¹èÀ̽Ä)
¹èÀÌ½Ä ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â
ü¿Ü¼öÁ¤(IVF)
ü¿Ü¼öÁ¤ ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â
Á¦6Àå µ¿¹° À¯Çü ÃßÁ¤¡¤µ¿Ç⠺м®, 2018-2030³â
µ¿¹° À¯ÇüÀÇ º¯µ¿ ºÐ¼®, 2018-2030³â
µ¿¹° À¯ÇüÀÇ º¯µ¿ ºÐ¼®°ú ½ÃÀå Á¡À¯À², 2023³â°ú 2030³â
µ¿¹° À¯Çüº°
¼Ò
¼Ò ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â
µÅÁö
µÅÁö ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â
¾ç
¾ç ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â
¿°¼Ò
¿°¼Ò ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â
¸»
¸» ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â
±âŸ µ¿¹°
±âŸ µ¿¹° ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â
Á¦7Àå À¯Åë ä³Î ÃßÁ¤¡¤µ¿Ç⠺м®, 2018-2030³â
À¯Åë ä³Îº° µ¿¹°¿ë º¸Á¶»ý½Ä±â¼ú ½ÃÀå : ÁÖ¿ä Æ÷ÀÎÆ®
À¯Åë ä³ÎÀÇ º¯µ¿ ºÐ¼®°ú ½ÃÀå Á¡À¯À², 2023³â°ú 2030³â
À¯Åë ä³Îº°
ÇÁ¶óÀ̺ø
ÇÁ¶óÀ̺ø ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â
°øÀû
°øÀû ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â
Á¦8Àå Áö¿ªÀÇ ÃßÁ¤¡¤µ¿Ç⠺м®, 2018-2030³â
Áö¿ªº° Àü¸Á
Áö¿ª ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â¡¤2030³â
Áö¿ªÀÇ ¸¶ÄÏÇ÷¹À̽º, ÁÖ¿ä Æ÷ÀÎÆ®
Áö¿ªÀÇ ¸¶ÄÏÇ÷¹À̽º, ÁÖ¿ä Æ÷ÀÎÆ®
Áö¿ªÀÇ ¸¶ÄÏÇ÷¹À̽º, ÁÖ¿ä Æ÷ÀÎÆ®
ºÏ¹Ì
ºÏ¹ÌÀÇ µ¿¹°¿ë º¸Á¶»ý½Ä±â¼ú ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â
¹Ì±¹
ij³ª´Ù
À¯·´
À¯·´ÀÇ µ¿¹°¿ë º¸Á¶»ý½Ä±â¼ú ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â
¿µ±¹
µ¶ÀÏ
ÇÁ¶û½º
ÀÌÅ»¸®¾Æ
½ºÆäÀÎ
³×´ú¶õµå
³ë¸£¿þÀÌ
µ§¸¶Å©
½º¿þµ§
¾Æ½Ã¾ÆÅÂÆò¾ç
¾Æ½Ã¾ÆÅÂÆò¾çÀÇ µ¿¹°¿ë º¸Á¶»ý½Ä±â¼ú ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â
Áß±¹
ÀϺ»
Àεµ
È£ÁÖ
Çѱ¹
ű¹
¶óƾ¾Æ¸Þ¸®Ä«
¶óƾ¾Æ¸Þ¸®Ä«ÀÇ µ¿¹°¿ë º¸Á¶»ý½Ä±â¼ú ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â
ºê¶óÁú
¸ß½ÃÄÚ
¾Æ¸£ÇîÆ¼³ª
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ µ¿¹°¿ë º¸Á¶»ý½Ä±â¼ú ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â
³²¾ÆÇÁ¸®Ä«°øÈ±¹
»ç¿ìµð¾Æ¶óºñ¾Æ
¾Æ¶ø¿¡¹Ì¸®Æ®
Äí¿þÀÌÆ®
Á¦9Àå °æÀï ±¸µµ
½ÃÀå Âü¿© ±â¾÷ ºÐ·ù
ÁÖ¿ä ±â¾÷ °³¿ä
Participants Overview
Financial Performance
Product Benchmarking
Strategy Mapping
Genus Plc
Urus Group Lp
Crv
Semex
Select Sires Inc.
Swine Genetics International
National Dairy Development Board
Stgenetics
Vikinggenetics
Geno Sa
Market Entry Strategies Analysis
½ÃÀå ÇöȲ ºÐ¼®, 2022³â(È÷Æ®¸Ê ºÐ¼®)
Á¦10Àå ÁÖ¿ä Æ÷ÀÎÆ®
KSA
¿µ¹® ¸ñÂ÷
Veterinary Assistive Reproduction Technology Market Growth & Trends:
The global veterinary assistive reproduction technology market size is expected to reach USD 4.27 billion by 2030, registering a CAGR of 7.42% from 2024 to 2030, according to a new report by Grand View Research, Inc . The key factors driving market growth include increasing advancements in veterinary assistive reproduction technologies, R&D activities, demand for animal protein, and a growing focus on improving animal breeding outcomes. The cost-effectiveness of artificial insemination is further influencing adoption rates in the livestock industry, where improved reproductive outcomes directly impact profitability. According to a study published in June 2019 in the National Library of Medicine Journal, embryo production with sexed semen (X-sorted) and follicular growth-stimulated (FGS) oocytes bred female calves more efficiently than other embryo sexing methods.
The COVID-19 pandemic and African Swine Fever notably impacted the market with slow growth, supply chain challenges, and operational hurdles. These factors affected certain markets (e.g. China) during 2022-23. However, as the underlying drivers remain unchanged, the market is expected to grow at a significant CAGR over the forecast period. The market dynamics also vary across regions, with different countries experiencing varying levels of adoption based on factors, such as animal population, economic conditions, cultural attitudes towards pets & livestock, and regulatory environments. Moreover, advancements in reproductive technologies have led to improved procedure success rates. This increased efficiency is expected to drive the adoption of veterinary assistive reproduction technologies in the near future.
The livestock segment accounted for the highest revenue share in 2023 and is anticipated to maintain its dominance over the forecast period. It is because the livestock sector has been adopting reproductive technologies to enhance breeding efficiency, improve the genetic traits of livestock, and boost agricultural productivity for a long time. Furthermore, the potential of various veterinary assistive reproduction technologies is projected to propel awareness, demand, and adoption of the same in the near future. For instance, the Brazilian Agricultural Research Corporation (Embrapa) estimated the potential of reproduction techniques with artificial insemination facilitating the obtention of a calf per year. Classic Embryo Transfer (ET) was estimated to produce one calf monthly, while IVF to breed one calf per week.
Veterinary Assistive Reproduction Technology Market Report Highlights:
Based on product, the normal semen segment dominated the industry in 2023, while the sexed semen segment is expected to grow at the fastest CAGR of over 8.0% from 2024 to 2030
The increasing awareness and uptake of veterinary assistive reproduction technologies are crucial factors contributing to market growth
In terms of distribution channel, the private segment held the highest revenue share in 2023 and is also expected to grow at the fastest CAGR from 2024 to 2030
The AI conception method segment led the industry in 2023. However, the IVF segment is estimated to register the fastest CAGR from 2024 to 2030
The bovine animal type segment accounted for the highest revenue share in 2023. The other animals segment is expected to grow at the fastest CAGR from 2024 to 2030
Ongoing R&D efforts focus on refining existing technologies, comparing existing technologies, and exploring new methods to enhance reproductive outcomes to address specific challenges in different animal species. It is estimated to support the segment growth
In 2023, North America accounted for the highest revenue share. Asia Pacific is anticipated to register the fastest CAGR from 2024 to 2030
Table of Contents
Chapter 1 Methodology And Scope
1.1 Market Segmentation And Scope
1.1.1 Regional Scope
1.1.2 Estimates And Forecast Timeline
1.1.3 Market Definitions & Scope
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 Gvr's Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4 Information/Data Analysis
1.4.1 Information Analysis
1.5 Market Formulation & Visualization
1.6 Data Validation & Publishing
1.7 Model Details
1.7.1 Approach 1: Commodity Flow Analysis
1.7.1.1 Commodity Flow Model
1.7.2 Global Market: Cagr Calculation
1.7.3 Approach 2: Ancillary/Parent Market Analysis - Hybrid Model
1.7.4 Global Market: Cagr Calculation
1.8 List Of Secondary Sources
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Product And Conception Method Snapshot
2.3 Animal Type And Distribution Channel Snapshot
2.4 Competitive Landscape Snapshot
Chapter 3 Veterinary Assistive Reproduction Technologies Market Industry Outlook
3.1 Market Lineage Outlook
3.1.1 Ancillary Market Analysis
3.2 Veterinary Assistive Reproduction Technologies Market Dynamics
3.2.1 Market Driver Impact Analysis
3.2.1.1 Increasing Demand For MEAt, Dairy, And Animal Protein Products
3.2.1.2 Developments In In-Vitro Fertilization (Ivf) And Embryo Transfer (Et)
3.2.1.3 Advancements In Assistive Reproduction Technology
3.2.1.4 Supportive Initiatives
3.2.2 Market Restraint Impact Analysis
3.2.2.1 Lack Of Awareness
3.2.2.2 Risk, Uncertainty, And Ethical Concerns
3.2.2.3 Limited Access To Supplies & Skilled Labor In Certain Countries
3.2.3 Market Opportunity Analysis
3.2.4 Market Challenge Analysis
3.3 Veterinary Assistive Reproduction Technologies Market: Porter's 5 Forces Analysis
3.3.1 Bargaining Power Of Buyers
3.3.2 Bargaining Power Of Suppliers
3.3.3 Threat Of New Entrants
3.3.4 Threat Of Substitutes
3.3.5 Competitive Rivalry
3.4 Veterinary Assistive Reproduction Technologies Market: Pestel Analysis
3.4.1 Political & Legal
3.4.2 Economic
3.4.3 Technological
3.4.4 Social & Environmental
3.5 Estimated Animal Population, 2022, By Key Countries & Key Species
3.6 Estimated Number Of Semen Sold By Key Country, 2022
3.7 Covid-19 Impact Analysis
3.8 Pricing Analysis, By Key Regions
3.9 Technology Trends
3.10 Qualitative Analysis Of Fecundation/Conception Rates
3.10.1 Factors Affecting Conception Rates
3.10.2 Research Studies/ Case Studies
Chapter 4 Product Estimates & Trend Analysis, 2018 - 2030 (USD Million)
4.1 Veterinary Assistive Reproduction Technologies Market By Product: Key Takeaways
4.2 Product Movement Analysis & Market Share, 2023 & 2030
4.3 Veterinary Assistive Reproduction Technologies Market Estimates & Forecast, By Product (USD Million)
4.4 Normal Semen
4.4.1 Normal Semen Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.5 Sexed Semen
4.5.1 Sexed Semen Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 5 Conception Method Estimates & Trend Analysis, 2018 - 2030 (USD Million)
5.1 Conception Method Movement Analysis, 2018-2030 (USD Million)
5.2 Conception Method Movement Analysis & Market Share, 2023 & 2030
5.3 Veterinary Assistive Reproduction Technologies Market Estimates & Forecast, By Conception Method (USD Million)
5.4 Artificial Insemination
5.4.1 Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.5 Embryo Transfer (Moet: Multiple Ovulation Embryo Transfer)
5.5.1 Embryo Transfer Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.6 In Vitro Fertilization (Ivf)
5.6.1 Ivf Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 6 Animal Type Estimates & Trend Analysis, 2018 - 2030 (USD Million)
6.1 Animal Type Movement Analysis, 2018-2030 (USD Million)
6.2 Animal Type Movement Analysis & Market Share, 2023 & 2030
6.3 Veterinary Assistive Reproduction Technologies Market Estimates & Forecast, By Animal Type (USD Million)
6.4 Bovine
6.4.1 Bovine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5 Swine
6.5.1 Swine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6 Ovine
6.6.1 Ovine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.7 Caprine
6.7.1 Caprine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.8 Equine
6.8.1 Equine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.9 Other Animals
6.9.1 Other Animals Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 7 Distribution Channel Estimates & Trend Analysis, 2018 - 2030 (USD Million)
7.1 Veterinary Assistive Reproduction Technologies Market By Distribution Channel: Key Takeaways
7.2 Distribution Channel Movement Analysis & Market Share, 2023 & 2030
7.3 Veterinary Assistive Reproduction Technologies Market Estimates & Forecast By Distribution Channel (USD Million)
7.4 Private
7.4.1 Private Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5 Public
7.5.1 Public Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 8 Regional Estimates & Trend Analysis, 2018 - 2030 (USD Million)
8.1 Regional Outlook
8.2 Regional Market Share Analysis, 2023 & 2030
8.3 Regional Marketplace, Key Takeaways
8.4 Regional Marketplace, Key Takeaways
8.5 Regional Marketplace, Key Takeaways
8.6 North America
8.6.1 North America Veterinary Assistive Reproduction Technologies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.2 U.S.
8.6.2.1 U.S. Veterinary Assistive Reproduction Technologies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.3 Canada
8.6.3.1 Canada Veterinary Assistive Reproduction Technologies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7 Europe
8.7.1 Europe Veterinary Assistive Reproduction Technologies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7.2 Uk
8.7.2.1 Uk Veterinary Assistive Reproduction Technologies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7.3 Germany
8.7.3.1 Germany Veterinary Assistive Reproduction Technologies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7.4 France
8.7.4.1 France Veterinary Assistive Reproduction Technologies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7.5 Italy
8.7.5.1 Italy Veterinary Assistive Reproduction Technologies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7.6 Spain
8.7.6.1 Spain Veterinary Assistive Reproduction Technologies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7.7 The Netherlands
8.7.7.1 The Netherlands Veterinary Assistive Reproduction Technologies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7.8 Norway
8.7.8.1 Norway Veterinary Assistive Reproduction Technologies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7.9 Denmark
8.7.9.1 Denmark Veterinary Assistive Reproduction Technologies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7.10 Sweden
8.7.10.1 Sweden Veterinary Assistive Reproduction Technologies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8 Asia Pacific
8.8.1 Asia Pacific Veterinary Assistive Reproduction Technologies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.2 China
8.8.2.1 China Veterinary Assistive Reproduction Technologies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.3 Japan
8.8.3.1 Japan Veterinary Assistive Reproduction Technologies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.4 India
8.8.4.1 India Veterinary Assistive Reproduction Technologies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.5 Australia
8.8.5.1 Australia Veterinary Assistive Reproduction Technologies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.6 South Korea
8.8.6.1 South Korea Veterinary Assistive Reproduction Technologies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.7 Thailand
8.8.7.1 Thailand Veterinary Assistive Reproduction Technologies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.9 Latin America
8.9.1 Latin America Veterinary Assistive Reproduction Technologies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.9.2 Brazil
8.9.2.1 Brazil Veterinary Assistive Reproduction Technologies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.9.3 Mexico
8.9.3.1 Mexico Veterinary Assistive Reproduction Technologies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.9.4 Argentina
8.9.4.1 Argentina Veterinary Assistive Reproduction Technologies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.10 MEA
8.10.1 MEA Veterinary Assistive Reproduction Technologies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.10.2 South Africa
8.10.2.1 South Africa Veterinary Assistive Reproduction Technologies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.10.3 Saudi Arabia
8.10.3.1 Saudi Arabia Veterinary Assistive Reproduction Technologies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.10.4 UAE
8.10.4.1 UAE Veterinary Assistive Reproduction Technologies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.10.5 Kuwait
8.10.5.1 Kuwait Veterinary Assistive Reproduction Technologies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 9 Competitive Landscape
9.1 Market Participant Categorization
9.2 Key Company Profiles
9.2.1 Participants Overview
9.2.2 Financial Performance
9.2.3 Product Benchmarking
9.2.4 Strategy Mapping
Genus Plc
Urus Group Lp
Crv
Semex
Select Sires Inc.
Swine Genetics International
National Dairy Development Board
Stgenetics
Vikinggenetics
Geno Sa
9.3 Market Entry Strategies Analysis
9.4 Market Position Analysis, 2022 (Heat Map Analysis)
Chapter 10 Key Takeaways
°ü·ÃÀÚ·á